CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- S-4/A Deal Registration Statement - Business Combination
- SC 13G/A Stake Amended Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Bylaws or fiscal year change · Other events
- UPLOAD Other SEC-generated Letter
- 8-K Event Shareholder vote results
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- DEF 14A Proxy Proxy Statement
- PRER14A Other PRER14A
- PRE 14A Proxy Proxy Statement (Preliminary)
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- S-4 Deal Registration Statement - Business Combination
- 8-K Event Auditor change
- 8-K Event Material agreement · Regulation FD disclosure
- 10-Q Report Quarterly Report
Page 10 of 13 · 258 filings